The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis

Lupus. 2002;11(7):454-7. doi: 10.1191/0961203302lu222cr.

Abstract

The case of a woman affected by an overlap syndrome systemic lupus erythematosus/polymyositis (PM), who presented with active myositis at the start of the pregnancy, is reported. Therapy with cyclosporin, corticosteroids, hydroxychloroquine and high-dose intravenous immunoglobulin induced a progressive remission of clinical and laboratory signs of myositis. At 33 weeks of gestation, after a premature pre-term rupture of membrane, a male child was delivered. Although premature, and small for gestational age, he had a normal growth, and did not show any clinical sign suggestive of immune deficiency. Lymphocyte phenotypical and functional studies, as well as response to vaccination, were also normal.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cyclosporine / adverse effects*
  • Female
  • Humans
  • Immune System / abnormalities*
  • Immune System / drug effects
  • Immunosuppressive Agents / adverse effects*
  • Infant, Newborn
  • Infant, Premature
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Polymyositis / drug therapy
  • Polymyositis / immunology
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / immunology
  • Prenatal Exposure Delayed Effects*

Substances

  • Immunosuppressive Agents
  • Cyclosporine